【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2013 14
2.2.1 AstraZeneca to Acquire Remaining 50% Interest in Diabetes Joint Venture from Bristol-Myers Squibb for US$4.3 Billion 14
2.2.2 Johnson & Johnson Prices Public Offering of Notes for US$3.5 Billion 15
2.2.3 OncoMed Pharma Enters into Co-Development Agreement with Celgene 16
2.2.4 Thermo Fisher Scientific Completes Public Offering of Notes for US$3.2 Billion 17
2.2.5 Genmab Expands Licensing Agreement With Janssen Biotech 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2013 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2013 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2013 21
3.1.1 Top M&A Deals in December 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2013 – December 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2013 24
3.2.1 Top Equity Offering Deals in December 2013 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2013 – December 2013 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2013 27
3.3.1 Top PE/VC Deals in December 2013 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2013 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2013 30
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2013–December 2013 32
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2013–December 2013 33
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2013 – December 2013 36
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2013 37
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2013 38
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 39
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2013 – December 2013 41
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2013 – December 2013 42
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 44
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2013 48
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2013 49
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2013 50
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2013 50
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2013 – December 2013 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 53
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2013 – December 2013 55
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 57
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 59
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2013 59
6.1.1 Oncology – Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2013 63
6.2.1 Central Nervous System – Deals of the Month 65
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2013 67
6.3.1 Infectious Diseases – Deals of the Month 69
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2013 70
6.4.1 Metabolic Disorders – Deal of the Month 72
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2013 73
6.5.1 Immunology – Dealsof the Month 75
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2013 76
6.6.1 Cardiovascular – Deal of the Month 77
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, December 2013 78
6.7.1 Respiratory – Deals of the Month 79
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2013 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2013 83
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2013 86
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2013 89
7.4.1 Rest of the World – Deals of the Month 90
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 91
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2013 – December 2013 91
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2013 – December 2013 93
9 Further Information 95
9.1 Methodology 95
9.2 About GlobalData 96
9.3 Disclosure information 97
9.4 Disclaimer 97
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：December 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for December 2013 in Pharmaceuticals
■ 発行日：2014年1月27日
■ 調査会社：GlobalData
■ 商品コード：GDATA403163519
■ 調査対象地域：グローバル
- 世界のオイルシェール市場分析：Analyzing the Global Oil Shale MarketThe term oil shale generally refers to any sedimentary rock that contains solid bituminous materials (called kerogen) that are released as petroleum-like liquids when the rock is heated in the chemical process of pyrolysis. Oil shale was formed millions of years ago by deposition of silt and organic debris on lake beds and sea bottoms. Over long periods of time, heat and pressure transformed the m …
- Pompe Disease：グローバル臨床試験レビューH1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2013" provides data on the Pompe Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pompe Disease. It includes an overview of the trial numbers and their recruitment status as per the …
- Hyperthyroidism：グローバル臨床試験レビューH2, 2013Hyperthyroidism Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H2, 2013" provides data on the Hyperthyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperthyroidism. It includes an overview of the trial numbers and their recruitment status as …
- 患者温度管理の世界市場分析：製品別（患者保温システム、患者冷却システム）、タイプ別（手術、循環器科、小児科、神経科）、エンドユーザー別（手術室、新生児ICU、ER、ICU）、セグメント予測、2014-2025The global patient temperature management market is anticipated to reach a value of USD 4.5 billion by 2025, according to a new report by Grand View Research, Inc. Growing number of surgical procedures is expected to have a huge impact on the demand for temperature management products. For instance, open heart surgeries require maintenance of patients’ temperature through blood cooling and, thereb …
- 世界のHIV感染症治療薬市場及びパイプラインインサイトThe rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.5 in 2013, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in …
- 中南米の歯科矯正装置市場The Latin American orthodontic supplies market is poised to reach USD 320.2 million by 2020 at a CAGR of 5.5% during the forecast period. Although mature markets (such as the Brazil and Mexico) hold larger shares in the orthodontic supplies market, Chile is expected to witness the highest growth during the forecast period. Factors such as the growing number of patients with malocclusions, decreasi …
- 世界の特殊・高性能フィルム市場動向（2014-2018）About Specialty and High-performance Films Specialty and high-performance films are thin films with unique properties such as high or low heat conductivity, barrier properties, special surface properties, high purity, and mechanical properties. Specialty and high performance films are thin films made from various polymers such as polypropylene, polyamide, polyethylene, polyvinyl chloride, polycarb …
- 自動車用ステンレス鋼管の世界市場分析：製品別（溶接チューブ、シームレスチューブ）、地域別{（北アメリカ（米国）、ヨーロッパ（ドイツ、英国）、アジア太平洋（中国、日本）、中南米（ブラジル）、中東、アフリカ）}、セグメント予測、2013 – 2024The global automotive stainless steel tube market is projected to reach USD 4.72 million by 2024, according to a new report by Grand View Research, Inc. Growing automotive industry is projected to be the biggest driver of this market over the forecast period. The market is segmented on the basis of product into welded and seamless. Advantages such as high strength, resistance to shocks due to coll …
- 脳電図(EEG)/筋電図(EMG)装置の世界市場About EEG and EMG Equipment EEG and EMG equipment are used to monitor and record electrical activity in the brain and muscles, respectively. The most important clinical use of EEG is in the diagnosis of epilepsy. It is also used to diagnose brain dysfunction, sleep disorders, dementia, coma, and brain death. Earlier, EEG was also used often in the diagnosis of brain tumor and head injury. However, …
- 世界の家庭用品（Homewares）市場動向（2014-2018）TechNavio's analysts forecast the Global Homewares market to grow at a CAGR of 4.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in household disposable income. The Global Homewares market has also been witnessing increasing demand from emerging economies. However, the low brand loyalty could pose a challenge to the growth of this mar …
- 高機能顔料の世界市場分析：製品別（有機、無機）、用途別（塗料、プラスチック、インク、化粧品）、セグメント予測The global High Performance Pigments Market is expected to reach USD 6.32 billion by 2022, according to a new report by Grand View Research, Inc. Growing of automotive coatings demand on account of increasing automobile production particularly in Asia Pacific is expected to remain a key driving factor for the global High Performance Pigments Market. The growth of global personal care industry is a …
- 心血管情報システム（CVIS）の世界市場予測The global cardiovascular information systems market is poised to reach USD 917.2 million by 2020 from USD 621.4 million in 2015, at a CAGR of 8.1%. Based on type, the cardiovascular information systems market is segmented into CVIS and C-PACS. The components market includes software, service, and hardware. On the basis of mode of operation, the market is segmented into web-based, onsite, and clou …
- 2014年戦略提言：Salmonella診断検査市場The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - P …
- 二硫化炭素の世界市場Carbon Disulphide (CAS 75-15-0) Market Research Report 2014 presents comprehensive data on carbon disulphide markets globally and regionally (Europe, Asia, North America etc.) The report includes carbon disulphide description, covers its application areas and related patterns. It overviews carbon disulphide market, names carbon disulphide producers and indicates its suppliers. Besides, the report …
- データセンター建設の世界市場2017-2021About Data Center Construction A data center is a centralized storehouse — physical or virtual — for remote storage, and processing of data and information. Data centers constitute the backbone of essential business operations. There is a significant growth in the enterprise application worldwide because of the use of advanced technologies to gain competitive advantage. Enterprises are focusing on …
